Cita APA (7a ed.)

Huang, W., Chen, Y., Wu, C., & Ko, Y. (2021). Cardiovascular outcomes and healthcare costs of liraglutide versus basal insulin for type 2 diabetes patients at high cardiovascular risk. Nature Portfolio.

Cita Chicago Style (17a ed.)

Huang, Wan-Chun, Yen-Chou Chen, Chung-Hsuen Wu, y Yu Ko. Cardiovascular Outcomes and Healthcare Costs of Liraglutide Versus Basal Insulin for Type 2 Diabetes Patients at High Cardiovascular Risk. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Huang, Wan-Chun, et al. Cardiovascular Outcomes and Healthcare Costs of Liraglutide Versus Basal Insulin for Type 2 Diabetes Patients at High Cardiovascular Risk. Nature Portfolio, 2021.